Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct;78(10):1229-33.
doi: 10.1007/s12098-011-0399-8. Epub 2011 Mar 9.

LY96, UPKIB mutations and TLR4, CD14, MBL polymorphisms in children with urinary tract infection

Affiliations

LY96, UPKIB mutations and TLR4, CD14, MBL polymorphisms in children with urinary tract infection

Pelin Ertan et al. Indian J Pediatr. 2011 Oct.

Abstract

Objective: To evaluate genetic variations of innate immune system such as mannose binding lectin (MBL), Toll like receptor 4 (TLR4), CD14, LY96 (MD2) and Uroplakin 1B (UPK1B) genes in children with recurrent urinary tract infection (UTI).

Methods: The study included 30 children with recurrent UTI and 30 healthy controls. Blood was drawn and analysed for genetic polymorphisms of MBL, TLR4 and CD14 genes by the PCR-RFLP method. Direct DNA sequencing analysis was performed for LY96 and UPK 1B gene mutation in 10 children from UTI group and 5 children from control group.

Results: TLR4 gene Thr399Ile polymorphism was not observed in any child. Genotype distribution and allele frequency of Asp299Gly polymorphism was similar in both groups (p = 0.55). Codon 54 polymorphism of the MBL gene was similar in UTI and control groups (p = 0.49). -159 CC/CT/TT genotypes of CD14 gene was similar between the two groups (p = 0.14). UPK1B and LY96 gene DNA sequence analysis was similar in UTI and control groups.

Conclusions: This study is the first study in which different parts of the innate immune system were evaluated in UTI etiopathogenesis in Turkish children. The results did not point out a significant role of any of the genes evaluated in this study.

PubMed Disclaimer

References

    1. Eur J Clin Invest. 2005 Apr;35(4):227-35 - PubMed
    1. Clin Exp Immunol. 2006 Aug;145(2):346-56 - PubMed
    1. Curr Opin Pediatr. 2006 Apr;18(2):148-52 - PubMed
    1. Gene. 2005 Jan 3;344:193-202 - PubMed
    1. Int Immunopharmacol. 2010 Jan;10(1):98-106 - PubMed

Publication types

LinkOut - more resources